A new discovery about osteoporosis suggests a potential treatment target for that brittle-bone disease and for bone loss from rheumatoid arthritis.
Sep 22, 2021
0
101
The government's COVID-19 travel plan will let new variants into the UK, warn experts in The BMJ today.
May 12, 2021
0
8
University of Saskatchewan (USask) researchers and partners at the City of Saskatoon (CoS) and the Saskatchewan Health Authority (SHA) have developed a COVID-19 early warning system by sampling and testing the city's wastewater ...
Nov 2, 2020
0
3
Lung cancer is the predominant cause of cancer related deaths. Within the main types of lung cancers, small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), NSCLC accounts for approximately 85%, with a poor ...
Mar 16, 2020
0
1
To understand the molecular bases of cancer, it is imperative to determine the genetic alterations responsible for the development and spread of this condition and to identify the mechanisms through which healthy cells become ...
Dec 2, 2019
0
35
Children under 5 years of age in Africa are much more likely to die than those in wealthy countries as a direct result of poor health outcomes linked to air pollution, unsafe water, lack of sanitation, an increased family ...
Oct 1, 2019
0
2
Traditional medicines mostly function as inhibitors, attacking the disease-relevant proteins that cause cancer, by binding to their accessible pockets. Following this strategy, only ~20% of all proteins are chemically addressable, ...
Aug 23, 2019
0
2
Biomedical engineers at Duke University have discovered a pharmaceutical target that, when activated, can reverse bone degradation caused by osteoporosis in mouse models of the disease.
Aug 21, 2019
0
43
Bone-related diseases are the most common cause of severe long-term pain and reduced quality of life for millions of people. They include osteoporosis, periodontitis and rheumatoid arthritis – the number of people suffering ...
Oct 8, 2018
0
1
An environmentally responsible formulation process that makes the immunosuppressant drug, Tacrolimus (TAC) more soluble, and hence more readily absorbed by the body, has been developed by A*STAR scientists.
Oct 4, 2018
0
3
